|
WO2021064162A1
|
|
Treatment of diseases caused by frame shift mutations
|
|
WO2021058710A1
|
|
Modelling method using a conditional variational autoencoder
|
|
WO2021048257A1
|
|
Bactericidal phage vectors
|
|
WO2021028596A1
|
|
Modulating extracellular matrix movement
|
|
WO2020245446A1
|
|
System and method for real-time multicolor shortwave infrared fluorescence imaging
|
|
WO2020245447A1
|
|
Method and device for imaging fluorescent proteins in near- and short-wave infrared
|
|
WO2020120724A1
|
|
Barn dust extract for the prevention and treatment of diseases
|
|
WO2020120495A1
|
|
In-vitro method for diagnosis and prognosis of a disease
|
|
WO2020053186A1
|
|
Microrna inhibitors for use in treating metabolic diseases
|
|
US2020056171A1
|
|
Novel recombinant hbv reporter system
|
|
EP3773640A1
|
|
Larval preparation of heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof
|
|
EP3768678A1
|
|
Traf 6 inhibitors
|
|
CN112074596A
|
|
Device and method for monitoring scar formation
|
|
WO2019016361A1
|
|
System for optoacoustic imaging, in particular for raster-scan optoacoustic mesoscopy, and method for optoacoustic imaging data processing
|
|
US2020126671A1
|
|
Method for determining the risk to develop type 1 diabetes
|
|
EP3638774A1
|
|
Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
|
|
US2020148781A1
|
|
Novel cd73 antibody, preparation and uses thereof
|
|
EP3567625A1
|
|
Device and method for mass spectroscopic analysis of particles
|
|
WO2018185260A1
|
|
Novel human hepatocyte-derived matrix for stem-cell differentiation and tissue repair
|
|
DE102018203488A1
|
|
Device and method for closing glass capillaries
|
